This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
midgardfinance.com
midgardfinance.com
did:plc:6elkozr74dmgtebnjmwcre7e
🇺🇸 $LLY has one molecule doing the work.
Tirzepatide went from $2.3bn to $14.9bn a quarter in two years under two labels: #Mounjaro for diabetes at $9.9bn, #Zepbound for obesity at $4.9bn.
6.4x in ten quarters.
midgardfinance.com/companies/LLY/
#pharma
2026-08-08T17:26:56.362Z